1.
Consolidation therapy with alemtuzumab prolongs remission of chronic lymphocytic leukaemia. Hematol Meeting Rep [Internet]. 2009 Jun. 17 [cited 2026 Apr. 19];1(5). Available from: https://journals.pagepress.net/hmr/article/view/636